Gene · 11277
Papers2,317
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,317
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel heterozygous TREX1 mutation in a juvenile systemic lupus erythematosus patient with severe cutaneous involvement treated successfully with Jak-inhibitors: a case report. | Front Immunol | 2023 | 38124732 | PubTator, text mining | PubMed |
| Advances in transposable elements: from mechanisms to applications in mammalian genomics. | Front Genet | 2023 | 38098473 | PubTator, text mining | PubMed |
| Radiotherapy, photodynamic therapy, and cryoablation-induced abscopal effect: Challenges and future prospects. | Cancer Innov | 2023 | 38090387 | PubTator, text mining | PubMed |
| Nuclear cGAS restricts L1 retrotransposition by promoting TRIM41-mediated ORF2p ubiquitination and degradation. | Nat Commun | 2023 | 38086852 | PubTator, text mining | PubMed |
| Radiotherapy Combination: Insight from Tumor Immune Microenvironment (TIME). | Avicenna J Med Biotechnol | 2023 | 38078341 | PubTator, text mining | PubMed |
| A zebrafish model of Ifih1-driven Aicardi-Goutières syndrome reproduces the interferon signature and the exacerbated inflammation of patients. | Front Immunol | 2023 | 38077314 | PubTator, text mining | PubMed |
| Transcriptional Landscape of Repetitive Elements in Psoriatic Skin from Large Cohort Studies: Relevance to Psoriasis Pathophysiology. | Int J Mol Sci | 2023 | 38069048 | PubTator, text mining | PubMed |
| Modulation of CD8+ T Cell Responses by Radiotherapy-Current Evidence and Rationale for Combination with Immune Checkpoint Inhibitors. | Int J Mol Sci | 2023 | 38069014 | PubTator, text mining | PubMed |
| Glabridin improves autoimmune disease in Trex1-deficient mice by reducing type I interferon production. | Mol Med | 2023 | 38066431 | PubTator, text mining | PubMed |
| Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study. | Front Med (Lausanne) | 2023 | 38034538 | PubTator, text mining | PubMed |
| Leveraging iPSC technology to assess neuro-immune interactions in neurological and psychiatric disorders. | Front Psychiatry | 2023 | 38025464 | PubTator, text mining | PubMed |
| Small molecule inhibitors for cancer immunotherapy and associated biomarkers - the current status. | Front Immunol | 2023 | 38022587 | PubTator, text mining | PubMed |
| Aicardi-Goutières Syndrome with Congenital Glaucoma Caused by Novel TREX1 Mutation. | J Pers Med | 2023 | 38003924 | PubTator, text mining | PubMed |
| Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms. | Genes (Basel) | 2023 | 38002991 | PubTator, text mining | PubMed |
| Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients' Plasma. | Biomedicines | 2023 | 38002055 | PubTator, text mining | PubMed |
| Cannflavins A and B with Anti-Ferroptosis, Anti-Glycation, and Antioxidant Activities Protect Human Keratinocytes in a Cell Death Model with Erastin and Reactive Carbonyl Species. | Nutrients | 2023 | 37960218 | PubTator, text mining | PubMed |
| TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells. | Nucleic Acids Res | 2023 | 37953292 | PubTator, text mining | PubMed |
| Understanding nucleic acid sensing and its therapeutic applications. | Exp Mol Med | 2023 | 37945923 | PubTator, text mining | PubMed |
| GAS-STING: a classical DNA recognition pathways to tumor therapy. | Front Immunol | 2023 | 37920470 | PubTator, text mining | PubMed |
| ARF1 prevents aberrant type I interferon induction by regulating STING activation and recycling. | Nat Commun | 2023 | 37914730 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11277/papers?page=11